Can we help you find something?

Can we help you find something?

Clinical Trials

Our Clinical Cancer Trials

Capital Health Cancer Center participates in many National Cancer Institute (NCI), university and pharmaceutical phase II and III clinical trials. Some studies lead to the discovery of new methods to detect and diagnose cancer, while others focus on innovative treatments before they become widely available.

Clinical trials offer patients the very latest in cancer care while giving physicians and researchers the opportunity to study the effectiveness of the treatment. Participation is entirely voluntary.

Our experienced oncologists and research nurses carefully review study criteria, potential benefits, risks, and other considerations with eligible patients for enrollment into a clinical study. Once enrolled, our Clinical Research Department staff carefully monitors patients throughout the research trial and is available to answer questions.

The National Cancer Institute has a brochure Taking Part in Cancer Treatment Research Studies to help you understand the details of clinical trials.

To learn more about our ongoing trials for cancer treatment and prevention, please contact Tina Bergner, RN, BSN, OCN, oncology clinical research coordinator, at 609-537-7042 or e-mail her at [email protected] for more information.

Active clinical trials currently being offered:

Brain studies

NRG-BN003: Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma.

MATCH studies

EAY131: Molecular Analysis for Therapy Choice (MATCH) – Patients enrolled in study will have a tumor biopsy for molecular characterization and those with molecular variants addressed by treatments included in the trial will be offered treatment. Patients with hystologically documented solid tumors and lymphomas whose disease has progressed following at least one line of standard systemic therapy or for whom no standard therapy exists will be registered on the screening step to undergo tumor biopsy and analysis.

Non-NCI Open Oncology Studies

Circulating tumor DNA exposure in peripheral blood using a novel process: a feasibility study sponsored by Quantgene, Inc. (Dr. Cataldo Doria, PI)

Metabolic gene signatures in tissue biopsies and circulating biomarkers in blood samples of patients with cancer in partnership with the Blumberg Institute (HCC – Dr. Cataldo Doria, PI)

Capital Health Tissue Biorepository (Dr. Krister Jones, PI)

CH Radiation Oncology - Establishing an anticipatory model for anxiety and depression through a screening tool for first time radiation oncology patients (Rona Remstein)

National Evidence-Based Oncology Navigation Metrics: Multisite Exploratory Study to Demonstate Value and Sustainability of Navigation Programs (Patricia Tatrai)

Comparison of Upper Extremity Range of Motion in Post-Mastectomy Patients with and without formal mobility exercise education and initiation at time of mastectomy (Dr. Lisa Allen, PI)

Rutgers Cancer Institute of New Jersey – African American Woman’s Circle of Health Breast Cancer Research Study

Dana-Faber/Brigham and Woman’s Cancer Center (Dr. Geoffrey Oxnard) – INHERIT EGFR (Genetic Mutation T790M Lung Registry Study)

Other resources:

KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to Treatment

KIYATEC, Inc. has announced that Capital Health has joined its U.S. clinical trial, 3D-PREDICT, to validate the company’s test as a patient-specific predictor of response to cancer therapies in glioblastoma (GBM) and anaplastic astrocytoma (AA) patients.

Capital Health Acquires Medical Facility in Lower Bucks County

As part of its ongoing expansion into Bucks County, Capital Health recently completed the purchase of a property at 280 Middletown Boulevard in Langhorne, PA.

Capital Health at Deborah – Emergency Services Satellite Emergency Department Launches at Deborah Heart and Lung Center

As of 12 a.m. on July 1, Capital Health assumed operation of the satellite emergency department (SED) located on the Browns Mills campus of Deborah Heart and Lung Center, Burlington County’s only fully licensed cardiac center.

View All News
View All Events